Supplementary Figures 1-12 from HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma

MLA

Keiran S.M. Smalley, et al. Supplementary Figures 1-12 from HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22471901.

APA

Keiran S.M. Smalley, J. William Harbour, Jonathan D. Licht, Uwe Rix, Silvya Stuchi Maria-Engler, Srikumar P. Chellappan, John M. Koomen, Bin Fang, Biswarup Saha, Fumi Kinose, Michael A. Durante, Michael F. Emmons, & Fernanda Faião-Flores. (2023). Supplementary Figures 1-12 from HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma. https://doi.org/10.1158/1078-0432.22471901

Chicago

Keiran S.M. Smalley, J. William Harbour, Jonathan D. Licht, Uwe Rix, Silvya Stuchi Maria-Engler, Srikumar P. Chellappan, John M. Koomen, et al. 2023. “Supplementary Figures 1-12 from HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma,” March. doi:10.1158/1078-0432.22471901.